{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:56:35Z","timestamp":1765979795609,"version":"3.48.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.encep.2025.01.003","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T08:18:30Z","timestamp":1742026710000},"page":"635-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical profiles, treatment adherence, and quality of life in patients with severe mental disorders treated with cyamemazine: A real-world observational study"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5567-8650","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Faug\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Achour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2590-2927","authenticated-orcid":false,"given":"Elo\u00efse","family":"Maakaron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5425-0337","authenticated-orcid":false,"given":"Pierre","family":"Verney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade","family":"Obadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Andrieu-Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-5062","authenticated-orcid":false,"given":"Antoine","family":"Lefrere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2460-1217","authenticated-orcid":false,"given":"Michel","family":"Cermolacce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3249-2030","authenticated-orcid":false,"given":"Guillaume","family":"Fond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0661-5781","authenticated-orcid":false,"given":"Christophe","family":"Lan\u00e7on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6392-9322","authenticated-orcid":false,"given":"Th\u00e9o","family":"Korchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.encep.2025.01.003_bib0290","doi-asserted-by":"crossref","first-page":"832","DOI":"10.30773\/pi.2024.0008","article-title":"The Association Between Prolactin Levels and Cognitive Function in Female Patients With Severe Mental Disorders","volume":"21","author":"Xu","year":"2024","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.encep.2025.01.003_bib0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.schres.2021.09.017","article-title":"Emotional and stigma-related experiences relative to being told one is at risk for psychosis","volume":"238","author":"Woodberry","year":"2021","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1016\/j.encep.2025.01.003_bib0300","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00406-022-01380-1","article-title":"Affective lability and social functioning in severe mental disorders","volume":"272","author":"H\u00f8egh","year":"2022","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.encep.2025.01.003_bib0305","first-page":"96","article-title":"[Current and future pharmacotherapy of severe psychiatric disorders]","volume":"157","author":"\u010ce\u0161kov\u00e1","year":"2018","journal-title":"Cas Lek Cesk"},{"key":"10.1016\/j.encep.2025.01.003_bib0310","first-page":"1029","article-title":"[Study of the pharmacological properties of 3-cyano-10-(3-dimethylamino-2-methylpropyl)-phenothiazine or cyamepromazine (R.P. 7.204)]","volume":"155","author":"Julou","year":"1961","journal-title":"C R Seances Soc Biol Fil"},{"issue":"2","key":"10.1016\/j.encep.2025.01.003_bib0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.encep.2008.03.007","article-title":"[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]","volume":"35","author":"Bret","year":"2009","journal-title":"Encephale"},{"issue":"2","key":"10.1016\/j.encep.2025.01.003_bib0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.psychres.2012.01.009","article-title":"Potential role of cortical 5-HT2A receptors in the anxiolytic action of cyamemazine in benzodiazepine withdrawal","volume":"198","author":"Benyamina","year":"2012","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.encep.2025.01.003_bib0325","doi-asserted-by":"crossref","first-page":"1021780","DOI":"10.3389\/fpsyt.2022.1021780","article-title":"Antipsychotic prescribing practices in real-life (APPREAL study): Findings from the French National Healthcare System Database (2007-2017)","volume":"13","author":"Rolland","year":"2022","journal-title":"Front Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.encep.2025.01.003_bib0330","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.09.025","article-title":"Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes","volume":"578","author":"Benyamina","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.encep.2025.01.003_bib0335","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s002130050010","article-title":"5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity","volume":"147","author":"Alvarez-Guerra","year":"2000","journal-title":"Psychopharmacology [Internet]"},{"issue":"7","key":"10.1016\/j.encep.2025.01.003_bib0340","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hup.718","article-title":"Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome","volume":"20","author":"Favre","year":"2005","journal-title":"Human Psychopharmacology: Clinical and Experimental [Internet]"},{"issue":"4","key":"10.1016\/j.encep.2025.01.003_bib0345","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejps.2007.09.003","article-title":"Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine","volume":"32","author":"Arbus","year":"2007","journal-title":"Eur J Pharm Sci [Internet]"},{"issue":"3","key":"10.1016\/j.encep.2025.01.003_bib0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1527-3458.2004.tb00023.x","article-title":"Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome","volume":"10","author":"Bourin","year":"2004","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.encep.2025.01.003_bib0355","unstructured":"Synapse. What is the mechanism of Cyamemazine? [Internet]. 2024 [cit\u00e9 9 sept 2024]. Disponible sur: https:\/\/synapse.patsnap.com\/article\/what-is-the-mechanism-of-cyamemazine."},{"issue":"7","key":"10.1016\/j.encep.2025.01.003_bib0360","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hup.718","article-title":"Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome","volume":"20","author":"Favre","year":"2005","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"1","key":"10.1016\/j.encep.2025.01.003_bib0365","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5005\/jp-journals-10067-0128","article-title":"Is there Any Relevance for the Use of Cyamemazine in the Treatment of Schizophrenia?","volume":"17","author":"Malandain","year":"2023","journal-title":"Indian J Private Psychiatr"},{"issue":"4","key":"10.1016\/j.encep.2025.01.003_bib0370","article-title":"Phenothiazines and their Evolving Roles in Clinical Practice: A Narrative Review","volume":"10","author":"Edinoff","year":"2022","journal-title":"Health Psychol Res [Internet]"},{"issue":"5","key":"10.1016\/j.encep.2025.01.003_bib0375","first-page":"639","article-title":"Therapeutic options for agitation in the intensive care unit","volume":"39","author":"Aubanel","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"2","key":"10.1016\/j.encep.2025.01.003_bib0380","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5498\/wjp.v4.i2.30","article-title":"What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders","volume":"4","author":"Chakrabarti","year":"2014","journal-title":"WJP"},{"issue":"04","key":"10.1016\/j.encep.2025.01.003_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/jbm.2017.54001","article-title":"Prevalence of Medication Non-Adherence among Psychiatric Patients in a Tertiary Hospital in Nigeria","volume":"05","author":"Chukwujekwu","year":"2017","journal-title":"JBM"},{"issue":"4","key":"10.1016\/j.encep.2025.01.003_bib0390","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Therap Adv Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2025.01.003_bib0395","doi-asserted-by":"crossref","DOI":"10.17795\/zjrms968","article-title":"Factors associated with drug non-adherence after discharge among patients with mood disorders hospitalized in Shahid Beheshti Hospital in Kerman: a prospective study","volume":"17","author":"Ghaffari-Nejad","year":"2015","journal-title":"Zahedan J Res Med Sci"},{"issue":"2","key":"10.1016\/j.encep.2025.01.003_bib0400","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40737-022-00301-8","article-title":"Mortality among Treatment Non-Adherent Persons with Mental Illness\u2013Findings from the Community Mental Health Centre in India","volume":"10","author":"Sriramalu","year":"2023","journal-title":"J Psychosoc Rehabil Ment Health"},{"issue":"1","key":"10.1016\/j.encep.2025.01.003_bib0405","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13643-020-1274-3","article-title":"Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis","volume":"9","author":"Semahegn","year":"2020","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.encep.2025.01.003_bib0410","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/wps.20060","article-title":"Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies","volume":"12","author":"Kane","year":"2013","journal-title":"World Psychiatry"},{"key":"10.1016\/j.encep.2025.01.003_bib0415","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2147\/PPA.S417608","article-title":"Psychiatric Patients\u2019 Perceived Health Control and Reactance: Implications for Medication Adherence","volume":"17","author":"De las Cuevas","year":"2023","journal-title":"PPA"},{"issue":"3","key":"10.1016\/j.encep.2025.01.003_bib0420","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.apnu.2016.01.010","article-title":"Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs)","volume":"30","author":"Beebe","year":"2016","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1016\/j.encep.2025.01.003_bib0425","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1874941001104010058","article-title":"Factors associated with medication adherence among psychiatric outpatients at substance abuse risk","volume":"4","author":"Magura","year":"2011","journal-title":"Open Addict J"},{"issue":"1","key":"10.1016\/j.encep.2025.01.003_bib0430","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00228-013-1582-9","article-title":"Risk factors for non-adherence to antidepressant treatment in patients with mood disorders","volume":"70","author":"De las Cuevas","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.encep.2025.01.003_bib0435","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s11136-020-02470-0","article-title":"Quality of life in patients with severe mental illness: a cross-sectional survey in an integrated outpatient health care model","volume":"29","author":"Bergh\u00f6fer","year":"2020","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.encep.2025.01.003_bib0440","first-page":"331","article-title":"Three diagnostic psychiatric subgroups in comparison to self-stigma, quality of life, disorder severity and coping management cross-sectional outpatient study","volume":"39","author":"Holubova","year":"2018","journal-title":"Neuro Endocrinol Lett"},{"issue":"4","key":"10.1016\/j.encep.2025.01.003_bib0445","doi-asserted-by":"crossref","first-page":"23","DOI":"10.17816\/CP83","article-title":"Stigma and Quality of Life among People Diagnosed with Mental Disorders: a Narrative Review","volume":"2","author":"Ciobanu","year":"2021","journal-title":"Consortium Psychiatricum"},{"key":"10.1016\/j.encep.2025.01.003_bib0450","doi-asserted-by":"crossref","first-page":"102003","DOI":"10.1016\/j.cpr.2021.102003","article-title":"The relationship between stigma and subjective quality of life in psychosis: A systematic review and meta-analysis","volume":"85","author":"Degnan","year":"2021","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.encep.2025.01.003_bib0455","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/NDT.S122483","article-title":"Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study","volume":"13","author":"Vrbova","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.encep.2025.01.003_bib0460","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1016\/j.eurpsy.2007.01.832","article-title":"Association between quality of life and self-stigma, insight, and adverse effects of medication in patients with depressive disorders","volume":"22","author":"Yen","year":"2007","journal-title":"Eur Psychiatr"},{"issue":"Suppl 1","key":"10.1016\/j.encep.2025.01.003_bib0465","first-page":"43","article-title":"Comorbid anxiety in patients with psychosis","volume":"21","author":"Dernovsek","year":"2009","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.encep.2025.01.003_bib0470","doi-asserted-by":"crossref","first-page":"669921","DOI":"10.3389\/fpsyt.2021.669921","article-title":"Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports","volume":"12","author":"Ordak","year":"2021","journal-title":"Front Psychiatry"},{"issue":"17","key":"10.1016\/j.encep.2025.01.003_bib0475","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and Management of the Metabolic Syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.encep.2025.01.003_bib0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2018.02.031","article-title":"Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study","author":"Osimo","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.encep.2025.01.003_bib0485","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2010.05.019","article-title":"The development of the S-QoL 18: A shortened quality of life questionnaire for patients with schizophrenia","volume":"121","author":"Boyer","year":"2010","journal-title":"Schizophrenia Res"},{"issue":"3","key":"10.1016\/j.encep.2025.01.003_bib0490","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/jcm11030743","article-title":"The Validity of the SQoL-18 in Patients with Bipolar and Depressive Disorders: A Psychometric Study from the PREMIUM Project","volume":"11","author":"Boyer","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.encep.2025.01.003_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.encep.2025.01.003_bib0500","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2016.10.023","article-title":"Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset","volume":"182","author":"Fond","year":"2017","journal-title":"Schizophrenia Res"},{"issue":"338","key":"10.1016\/j.encep.2025.01.003_bib0505","first-page":"218","article-title":"Clinical global impression scale. The ECDEU Assessment Manual for Psychopharmacology-Revised Volume","volume":"76","author":"Guy","year":"1976","journal-title":"DHEW Publ No ADM"},{"key":"10.1016\/j.encep.2025.01.003_bib0510","first-page":"95","article-title":"The factor structure of the state-trait anxiety inventory","volume":"7","author":"Spielberger","year":"1980","journal-title":"Stress Anxiety"},{"issue":"22","key":"10.1016\/j.encep.2025.01.003_bib0515","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/S0007125000292581","article-title":"Assessing depression in schizophrenia: the Calgary Depression Scale","author":"Addington","year":"1993","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.encep.2025.01.003_bib0520","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.psychres.2018.06.062","article-title":"Toward a transdiagnostic tool to evaluate depressive symptoms across mental disorders: Validation of the Calgary depression rating scale in patients with major depressive disorder","volume":"268","author":"Micoulaud-Franchi","year":"2018","journal-title":"Psychiatr Res"},{"issue":"9","key":"10.1016\/j.encep.2025.01.003_bib0525","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict"},{"issue":"4","key":"10.1016\/j.encep.2025.01.003_bib0530","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/107319110100800409","article-title":"The Suicidal Behaviors Questionnaire-Revised (SBQ-R): validation with clinical and nonclinical samples","volume":"8","author":"Osman","year":"2001","journal-title":"Assessment"},{"key":"10.1016\/j.encep.2025.01.003_bib0535","doi-asserted-by":"crossref","first-page":"110779","DOI":"10.1016\/j.pnpbp.2023.110779","article-title":"Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study","volume":"126","author":"Fond","year":"2023","journal-title":"Progress Neuro-Psychopharmacol Biol Psychiatry"},{"year":"2015","series-title":"Prescrire les antipsychotiques: propri\u00e9t\u00e9s et modalit\u00e9s d\u2019utilisation","author":"Franck","key":"10.1016\/j.encep.2025.01.003_bib0540"},{"issue":"1\u20132","key":"10.1016\/j.encep.2025.01.003_bib0545","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/j.1440-1614.2005.01510.x","article-title":"Disability, Employment and Work Performance Among People with ICD-10 Anxiety Disorders","volume":"39","author":"Waghorn","year":"2005","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2025.01.003_bib0550","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mppsy.2007.01.007","article-title":"Epidemiology of anxiety disorders","volume":"6","author":"Michael","year":"2007","journal-title":"Psychiatry"},{"issue":"Suppl 3","key":"10.1016\/j.encep.2025.01.003_bib0555","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1016\/j.respe.2013.06.001","article-title":"Social determinants of health-related quality of life","volume":"61","author":"Kivits","year":"2013","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"6","key":"10.1016\/j.encep.2025.01.003_bib0560","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/met.2023.0003","article-title":"Antipsychotic-Induced Metabolic Syndrome: A Review","volume":"21","author":"Akinola","year":"2023","journal-title":"Metab Syndr Relat Disord"},{"issue":"7","key":"10.1016\/j.encep.2025.01.003_bib0565","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00406-022-01384-x","article-title":"Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ)","volume":"272","author":"Sunhary De Verville","year":"2022","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.encep.2025.01.003_bib0570","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpsychires.2017.06.008","article-title":"Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort","volume":"94","author":"Godin","year":"2017","journal-title":"J Psychiatr Res"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700625000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700625000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:51:51Z","timestamp":1765979511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700625000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0013700625000363"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2025.01.003","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical profiles, treatment adherence, and quality of life in patients with severe mental disorders treated with cyamemazine: A real-world observational study","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2025.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}